QA1.792 Billable / specific Li Fraumeni syndrome

ICD-10-CM QA1.792 identifies “Li Fraumeni syndrome” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 17: Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders

Exempt from present-on-admission reporting

Code-level instructions

No additional notes.

Inherited instructions

Chapters 17 · Congenital malformations, deformations, chromosomal abnormalities, and genetic disorders (Q00-QA1)

Excludes 21

inborn errors of metabolism (E70-E88)

Note1

Codes from this chapter are not for use on maternal records

QA1 · Genetic disorders associated with neoplasms, not elsewhere classified

Excludes 21

multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Code also4
  • , if applicable, any associated conditions, such as:
  • genetic susceptibility to malignant neoplasm by site (Z15.0-)
  • malignant neoplasms (C00.0-C96.9)
  • personal history of malignant neoplasm (Z85.-)
Official index references

Official index references (1)

Syndrome (1)

Official conversion history

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Release dates 2026-10-01

Previous assignment: Z15.09

History

Code history

Latest recorded change · FY2027

ChangedUnchanged
FY2027Selected edition

Effective from

  • Added

Li Fraumeni syndrome

Billable diagnosis code

CDC/NCHS · FY2027

All editions (1)

All editionsEffective fromCode history
FY20272026-10-01Added

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.